It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
Reinforcing commitment to ethical and sustainable growth
The agreement complements other PPAs for Sandoz production sites globally
This strategic investment strengthens Cohance's integrated oligonucleotide platform
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Subscribe To Our Newsletter & Stay Updated
